Hypertension pipeline spans 110+ drugs as 100+ companies advance clinical development
AI Summary- DelveInsight identifies more than 100 companies developing over 110 hypertension pipeline drugs.
- Approximately 40 hypertension drugs are in late-stage development, the report says.
- The report covers clinical trials, regulatory pathways, commercial analysis, licensing activity and market outlook.